Literature DB >> 32194750

C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.

Eriko Nozaki1, Takaaki Kobayashi2, Hiroaki Ohnishi1, Kouki Ohtsuka1, Tadahiko Masaki3, Takashi Watanabe1, Masanori Sugiyama3.   

Abstract

The chemokine CXCL10 and its receptor CXCR3 have been demonstrated to be implicated in cancer cell proliferation and metastasis. CXCR3 has three splice variants: CXCR3A, CXCR3B and CXCR3-alt. CXCR3A and B serve multiple roles in the growth and invasiveness of a number of cancer types. However, the roles of CXCR3 isoforms in colorectal cancer (CRC) cells remain unclear. In the current study, the effects of CXCL10 and CXCR3 isoforms on proliferation and invasion of CRC cells was examined. Proliferation and invasiveness of the CRC cell line HCT116, which were transfected with CXCR3A or CXCR3B in the presence of CXCL10, were evaluated in vitro using MTT, scratch wound healing and transwell assays. MTT assay indicated that regardless of the presence or absence of CXCL10, the proliferative ability of CXCR3A-transfected HCT116 cells was enhanced compared with blank and mock cells. Scratch wound healing and transwell assays indicated that invasiveness of CXCR3A-transfected cells was greater compared with blank and mock cells. However, HCT116 cells transfected with CXCR3B did not exhibit changes in their proliferative or invasive ability. mRNA expression of MMP9, which is associated with signaling downstream of the CXCL10/CXCR3A pathway, was increased 4-fold in CXCR3A-transfected HCT116 cells compared with control cells. The results of the present study indicated that CXCL10-enhanced proliferation and invasiveness of the CRC cell line HCT116 was likely mediated by CXCR3A, but not by CXCR3B.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  CXCR3 isoform; cellular invasiveness; cellular migration; cellular proliferation; colorectal cancer

Year:  2020        PMID: 32194750      PMCID: PMC7039108          DOI: 10.3892/ol.2020.11326

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

2.  Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Authors:  Karin Jöhrer; Claudia Zelle-Rieser; Alexander Perathoner; Patrizia Moser; Martina Hager; Reinhold Ramoner; Hubert Gander; Lorenz Höltl; Georg Bartsch; Richard Greil; Martin Thurnher
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

Review 3.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

4.  Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer.

Authors:  Yuji Toiyama; Hiroyuki Fujikawa; Mikio Kawamura; Kohei Matsushita; Susumu Saigusa; Koji Tanaka; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Oncol       Date:  2011-10-31       Impact factor: 5.650

5.  Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.

Authors:  Kenji Kawada; Masahiro Sonoshita; Hiromi Sakashita; Arimichi Takabayashi; Yoshio Yamaoka; Toshiaki Manabe; Kayo Inaba; Nagahiro Minato; Masanobu Oshima; Makoto Mark Taketo
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

6.  CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Authors:  Zheng Jiang; Ye Xu; Sanjun Cai
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

Review 7.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

8.  Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Authors:  Qian Wu; Rajiv Dhir; Alan Wells
Journal:  Mol Cancer       Date:  2012-01-11       Impact factor: 27.401

9.  Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.

Authors:  S C Wightman; A Uppal; S P Pitroda; S Ganai; B Burnette; M Stack; G Oshima; S Khan; X Huang; M C Posner; R R Weichselbaum; N N Khodarev
Journal:  Br J Cancer       Date:  2015-06-04       Impact factor: 7.640

10.  CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.

Authors:  Ming Bai; Xia Chen; Y I Ba
Journal:  Mol Clin Oncol       Date:  2015-10-30
View more
  2 in total

1.  Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors.

Authors:  Emily Tsutsumi; Jeremiah Stricklin; Emily A Peterson; Joyce A Schroeder; Suwon Kim
Journal:  Mol Cell Biol       Date:  2021-12-06       Impact factor: 5.069

2.  Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells.

Authors:  Leonardo Marques da Fonseca; Lucas Rodrigues Jacques da Silva; Jhenifer Santos Dos Reis; Marcos André Rodrigues da Costa Santos; Victoria de Sousa Chaves; Kelli Monteiro da Costa; Julliana de Nazareth Sa-Diniz; Celio Geraldo Freire de Lima; Alexandre Morrot; Tatiany Nunes Franklim; Douglas Chaves de Alcântara-Pinto; Marco Edilson Freire de Lima; Jose Osvaldo Previato; Lucia Mendonça-Previato; Leonardo Freire-de-Lima
Journal:  Medicines (Basel)       Date:  2020-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.